UDR (NYSE:UDR – Get Free Report) updated its second quarter earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $0.60-$0.62 for the period, compared to the consensus estimate of $0.61. UDR also updated its FY 2024 guidance to 2.120-2.240 EPS.
UDR Stock Down 0.5 %
Shares of NYSE:UDR traded down $0.21 during midday trading on Tuesday, hitting $38.08. 3,263,255 shares of the stock were exchanged, compared to its average volume of 2,946,120. The company has a market capitalization of $12.54 billion, a PE ratio of 28.55, a P/E/G ratio of 3.03 and a beta of 0.80. UDR has a 52-week low of $30.95 and a 52-week high of $44.02. The company has a debt-to-equity ratio of 1.47, a quick ratio of 5.15 and a current ratio of 5.15. The business’s fifty day simple moving average is $36.78 and its two-hundred day simple moving average is $35.97.
UDR Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 30th. Stockholders of record on Wednesday, April 10th will be paid a dividend of $0.425 per share. The ex-dividend date of this dividend is Tuesday, April 9th. This is an increase from UDR’s previous quarterly dividend of $0.42. This represents a $1.70 dividend on an annualized basis and a dividend yield of 4.46%. UDR’s dividend payout ratio (DPR) is 126.87%.
Analyst Ratings Changes
Check Out Our Latest Report on UDR
About UDR
UDR, Inc (NYSE: UDR), an S&P 500 company, is a leading multifamily real estate investment trust with a demonstrated performance history of delivering superior and dependable returns by successfully managing, buying, selling, developing and redeveloping attractive real estate communities in targeted U.S.
Further Reading
- Five stocks we like better than UDR
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Ride Out The Recession With These Dividend KingsĀ
- Hilton Demonstrates Asset Light is Right for Investors
- Most active stocks: Dollar volume vs share volume
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for UDR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UDR and related companies with MarketBeat.com's FREE daily email newsletter.